Wafa T Al-Jamal Selected Research

L 377202

1/2022	Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy.
1/2019	Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wafa T Al-Jamal Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 03/2009
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2019
4	Hyperthermia 01/2022 - 01/2020
1	Stroke (Strokes) 01/2022
1	Brain Ischemia (Cerebral Ischemia) 01/2022
1	Reperfusion Injury 01/2022
1	Hypersensitivity (Allergy) 10/2020
1	Adenocarcinoma 04/2016
1	Colonic Neoplasms (Colon Cancer) 09/2015
1	Chronic Disease (Chronic Diseases) 09/2015
1	Lung Neoplasms (Lung Cancer) 07/2015
1	Melanoma (Melanoma, Malignant) 03/2009

Drug/Important Bio-Agent (IBA)

5	Liposomes (Liposome)IBA 01/2022 - 03/2009
3	ProdrugsIBA 01/2022 - 01/2019
3	Peptides (Polypeptides)IBA 01/2022 - 01/2019
3	Biological ProductsIBA 01/2022 - 07/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2019
2	L 377202IBA 01/2022 - 01/2019
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2022 - 09/2015
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 01/2019
2	Docetaxel (Taxotere)FDA Link 10/2020 - 01/2016
2	NanocapsulesIBA 12/2016 - 09/2015
1	scutellarinIBA 01/2022
1	flavoneIBA 01/2022
1	LigandsIBA 10/2021
1	resazurinIBA 10/2021
1	CytokinesIBA 10/2021
1	Monoclonal AntibodiesIBA 10/2020
1	Cetuximab (Erbitux)FDA Link 10/2020
1	Polysorbates (PSML)FDA Link 10/2020
1	Surface-Active Agents (Surfactants)IBA 10/2020
1	Antimitotic AgentsIBA 10/2020
1	Antineoplastic Agents (Antineoplastics)IBA 04/2016
1	BromidesIBA 04/2016
1	ThioureaIBA 04/2016
1	ErbB Receptors (EGF Receptor)IBA 04/2016
1	SiliconIBA 04/2016
1	CurcuminIBA 09/2015
1	Small Interfering RNA (siRNA)IBA 07/2015
1	Carbon Nanotubes (Carbon Nanotube)IBA 07/2015
1	1,2-distearoyllecithinIBA 03/2009
1	1,2- distearoyl- sn- glycero- 3- phosphoethanolamine- N- methoxy- poly(ethylene glycol 2000)IBA 03/2009
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 03/2009

Therapy/Procedure

4	Therapeutics 01/2022 - 07/2015
3	Intravenous Administration 01/2022 - 03/2009
2	Injections 01/2022 - 07/2015
1	Thrombolytic Therapy 01/2022
1	Precision Medicine 02/2021
1	Castration 01/2019
1	Quantum Dots (Quantum Dot) 03/2009